Showing results (711-720 of 2,354) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|July 15, 2000
New antiepileptic drugs in children: which ones for which seizures?B F BourgeoisClinical Neuropharmacology|July 15, 2000
Sertraline-induced panic attacksG Catalano, S M Hakala, M C CatalanoClinical Neuropharmacology|June 15, 1999
Neuropharmacologic aspects of apoptosis: significance for neurodegenerative diseasesP P Michel, N Lambeng, M RubergClinical Neuropharmacology|June 15, 1999
Neurophysiologic and neuropsychologic profiles of lamotrigine in epilepsyM G Marciani, F Spanedda, D MattiaClinical Neuropharmacology|June 15, 1999
Novel targets for therapeutic intervention against ischemic brain injuryA Sun, J ChengClinical Neuropharmacology|June 15, 1999
Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxietyI H Richard, E Szegethy, D Lichter, et al.Clinical Neuropharmacology|October 12, 1999
Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeysV D Doan, R Grondin, A Hadj Tahar, et al.Clinical Neuropharmacology|October 12, 1999
Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacyH Grunze, A Erfurth, J WaldenClinical Neuropharmacology|August 12, 1999
A study of salivary secretion in Parkinson's diseaseH Bagheri, C Damase-Michel, M Lapeyre-Mestre, et al.Clinical Neuropharmacology|August 12, 1999
Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuationsR de la Fuente-FernándezPageof 236